This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Panoff JE, Hrely J, Takita C, Reis IM, Zhao W, Sujoy V, Gomez CR, Jorda M, Koniaris I, Wright JL (2011) Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat. doi:10.1007/s10549-011-1495-1
Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Warlam-Rodenhuis CC, Pierart M, Collette L (2007) Impact of a higher radiation dose on local control and survival in breast conserving therapy of early breast cancer: 10 year results of the randomized boost versus no boost trial of EORTC 22881–10882 Trial. J Clin Oncol 25:3259–3265
Comen EA, Robson M (2010) Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J 16:48–52
Efimova EV, Mauceri HJ, Golden DW, Labay E, Bindokas VP, Darga TE, Chakraborty C, Barreto-Andrade JC, Crawley C, Sutton HG, Kron SJ, Weichselbaum RR (2010) Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res 70:6277–6282
Liu SK, Coackley C, Krause M, Jalali F, Chan N, Bristow RG (2008) A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia. Radiother Oncol 88(2):258–268
Taghian A, Jeong J-H, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N (2004) Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22(21):4247–4254
References for Rebuttal letter
Panoff JE, Takita C, Hurley J et al (2011) Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys [Epub ahead of print]
Conflict of interest
About this article
Cite this article
Graham, P. Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat 130, 353–355 (2011). https://doi.org/10.1007/s10549-011-1598-8